Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials
In Brief: NIH Reviewers, Advisors To Get Increase In Honoraria; Price Leaving NCI for Maryland
Recision, 1981 Budget Threats Hangover NCI
Frelick Heads ACCC, Kerman Names President-Elect
CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients
Skipper To Receive Bristol-Myers Award
Pathology Review Confirms Reserpine As Carcinogen
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- CBER Director Vinay Prasad dared to “say no to drugs”









